Published in J Am Coll Cardiol on November 01, 2016
The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? Eur Heart J (2015) 0.95
TCT-77 Association of Residual Mitral Regurgitation after Transcatheter Aortic Valve Replacement with Readmission for Acute Heart Failure: An Analysis from PARTNER 1. J Am Coll Cardiol (2016) 0.75
TCT-351 Coronary sinus reducer implantation for the treatment of chronic refractory angina: a single center experience. J Am Coll Cardiol (2016) 0.75
TCT-665 Association of Paravalvular Leak after Transcatheter Aortic Valve Replacement with Readmission for Acute Heart Failure: An Analysis from PARTNER 1. J Am Coll Cardiol (2016) 0.75
TCT-691 Sex-Specific Differences After Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients: An Analysis from the PARTNER 2 Randomized Trial. J Am Coll Cardiol (2016) 0.75
TCT-420 Incidence of side branch occlusions following bioresorbable scaffold implantation for long left anterior descending artery lesions. J Am Coll Cardiol (2016) 0.75
TCT-815 Clinical benefits of less-invasive, device-based Left Ventricular Reconstruction: A hybrid option for patients with ischemic cardiomyopathy. J Am Coll Cardiol (2016) 0.75
TCT-85 Prevalence of tricuspid regurgitation and its impact on mid-term outcomes: insights from a tertiary referral center. J Am Coll Cardiol (2016) 0.75
TCT-88 Innovative Transcatheter Tricuspid Valve Repair System. Initial Outcomes from the First in Human Multi-Centre Study. J Am Coll Cardiol (2016) 0.75
TCT-716 A DW-MRI and MSCT-Study to assess predictors of cerebral embolism during transcatheter aortic valve implantation. J Am Coll Cardiol (2016) 0.75
TCT-639 The Impact of Mitral Regurgitation Severity on Efficacy of Percutaneous Mitral Valve Annuloplasty in Functional Mitral Regurgitation. J Am Coll Cardiol (2016) 0.75
TCT-679 Diabetes and Clinical Outcomes in Intermediate Risk Patients Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: An Analysis of the PARTNER 2A Trial. J Am Coll Cardiol (2016) 0.75
TCT-640 Percutaneous Mitral Valve Annuloplasty Patients with Minimal Acute Reduction in Mitral Regurgitation Improve Long Term (from the TITAN II trial). J Am Coll Cardiol (2016) 0.75
TCT-38 Paravalvular Regurgitation Regression and Impact on 1-year Outcomes After Transcatheter Aortic Valve Replacement with the SAPIEN 3 Transcatheter Valve. J Am Coll Cardiol (2016) 0.75
TCT-615 Do patients with CKD benefit from Left Atrial Appendage Closure (LAAC) with WATCHMAN? Insights from PROTECT AF. J Am Coll Cardiol (2016) 0.75
TCT-42 Transcatheter echo guided Mitral Valve Repair with Neochord Implantation for posterior leaflet disease: Results from Neochord Independent International Registry. J Am Coll Cardiol (2016) 0.75
TCT-678 Incidence, Predictors and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve Implantation for Degenerative Bioprosthetic Surgical Valves: Insights from the VIVID Registry. J Am Coll Cardiol (2016) 0.75
TCT-419 Usefulness of a scoring system for predicting adverse cardiovascular events in patients undergoing everolimus-eluting bioresorbable scaffolds implantation: the PSP score. J Am Coll Cardiol (2016) 0.75
TCT-400 The importance of implantation technique in ensuring optimal outcomes after bioresorbable scaffold implantation: implications from a real-world cohort. J Am Coll Cardiol (2016) 0.75
TCT-437 Clinical outcome of coronary bifurcation management with a "fully bioresorbable" technique. Results of the multicentre BBS study. J Am Coll Cardiol (2016) 0.75
TCT-506 Coronary sinus reduction improves myocardial perfusion reserve index assessed by dipyridamole stress cardiac magnetic resonance. J Am Coll Cardiol (2016) 0.75
TCT-418 Procedural and mid-term outcomes of Bioresorbable scaffOlds versus drug-elutiNg stents In chronic Total Occlusions: the BONITO Registry. J Am Coll Cardiol (2016) 0.75
TCT-394 Impact of inadequate angiographic results after pre-dilatation on clinical outcomes following drug-coated balloon treatment for in-stent restenosis. J Am Coll Cardiol (2016) 0.75
TCT-436 Multi-Center, Post-marketing Evaluation of the Elixir DESolve® Novolimus Eluting Bioresorbable Coronary Stent System: 6-month Results from the DESolve PMCF Study. J Am Coll Cardiol (2016) 0.75
TCT-826 Prospective single center First In Human (FIH) clinical trial to evaluate the safety and effectiveness of a septal occluder with bioresorbable framework in patients with clinically significant atrial septum defect (ASD) or patent foramen ovale (PFO). J Am Coll Cardiol (2016) 0.75
TCT-460 Multi-Center, Randomized Evaluation of the Elixir DESyne® Novolimus Eluting Coronary Stent System with Biodegradable Polymer Compared to a Zotarolimus-Eluting Coronary Stent System: Final 5-Year Results from the EXCELLA BD Study. J Am Coll Cardiol (2016) 0.75
TCT-41 Up to two years follow up results of mitral valve transcatheter annuloplasty system for mitral reconstruction multi-center trial. J Am Coll Cardiol (2016) 0.75
TCT-654 Risk of Readmission for Acute Heart Failure, Subsequent Readmission, and Mortality Following Transcatheter Aortic Valve Replacement: An Analysis from PARTNER 1. J Am Coll Cardiol (2016) 0.75
TCT-674 Sex Specific Outcomes of TAVR with the Sapien 3 Valve: Insights From The PARTNER 2 S3 High-Risk and Intermediate-Risk Cohorts. J Am Coll Cardiol (2016) 0.75
TCT-699 Anatomic Deployment Index: A Novel Measure of SAPIEN 3 Transcatheter Heart Valve Performance. J Am Coll Cardiol (2016) 0.75
TCT-652 Incidence, Predictors and Clinical Outcomes of Device Malposition Following Transcatheter Aortic Valve Implantation for Degenerative Bioprosthetic Surgical Valves: Insights from the VIVID Registry. J Am Coll Cardiol (2016) 0.75
TCT-751 ONE-YEAR CLINICAL OUTCOMES ACCORDING TO ANTITHROMBOTIC REGIMEN AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION. J Am Coll Cardiol (2016) 0.75
TCT-819 Clinical Outcome in Patients with Heart Failure and Moderate Aortic Stenosis. J Am Coll Cardiol (2016) 0.75
TCT-229 Safety and Efficacy of Rotational Atherectomy for the Treatment of Undilatable Underexpanded Stents Implanted in Calcific Lesions. J Am Coll Cardiol (2016) 0.75
TCT-698 Comparison of the fully repositionable and retrievable Lotus Valve and Direct Flow Medical Valve for the treatment of severe aortic stenosis: a high-volume single center experience. J Am Coll Cardiol (2016) 0.75
TCT-670 Optimal Transcatheter Heart Valve Sizing in Aortic Valve in Valve Implantation: Insights from the Valve in Valve International Data (VIVID) Registry. J Am Coll Cardiol (2016) 0.75
TCT-361 Targeting Transradial Approach: an Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Coll Cardiol (2016) 0.75
TCT-32 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 4-Year Clinical and Imaging Results. J Am Coll Cardiol (2016) 0.75
TCT-401 Bioresorbable Scaffolds And Thrombosis: Insights From The GHOST-EU (Gauging coronary Healing with biOresorbable Scaffolding plaTforms in Europe) Registry. J Am Coll Cardiol (2016) 0.75